Zurich Cantonal Bank’s Trillium Therapeutics Inc. TRIL Stock Holding History

Zurich Cantonal Bank’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,424	Closed	-$183K	–	2975
2021 Q3	$183K	Hold	10,424	–	–	﹤0.01%	1985
2021 Q2	$102K	Hold	10,424	–	–	﹤0.01%	2219
2021 Q1	$112K	Hold	10,424	–	–	﹤0.01%	2099
2020 Q4	$153K	Buy	+10,424	New	+$150K	﹤0.01%	2000

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Zurich Cantonal Bank's TRIL Position: Q4 2021 in Review

Zurich Cantonal Bank sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,424 shares — an estimated $183K sold.

Zurich Cantonal Bank first reported a position in TRIL in Q4 2020 and held it in 4 quarters. The position peaked at $183K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Zurich Cantonal Bank reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Zurich Cantonal Bank sold 10,424 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $183K.
Zurich Cantonal Bank first reported a position in Trillium Therapeutics Inc. in Q4 2020 and held it in 4 quarters.
Zurich Cantonal Bank's Trillium Therapeutics Inc. position peaked at $183K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.